Results 81 to 90 of about 4,030,812 (306)

Change Point Detection Based on Cluster Transition Distributions

open access: yesIEEE Access
Nowadays, Anomaly Detection (AD) models are incorporated into various systems, but they will become useless if they are not updated (i.e., re-trained) to keep up with changes in their external environment.
Shoko Takahashi   +3 more
doaj   +1 more source

CHANGE DETECTION FROM POINT CLOUDS TO SUPPORT INDOOR 3D CADASTRE [PDF]

open access: yesThe International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, 2018
Recently in The Netherlands, there are many examples of changes in the functionalities of buildings over time. Tracking these changes could be challenging when the building geometry will change as well; for example a change from administrative to ...
S. Nikoohemat   +3 more
doaj   +1 more source

An Evaluation of Change Point Detection Algorithms

open access: yesCoRR, 2020
For code and data, see https://github.com/alan-turing-institute/TCPDBench ; Changelog in ...
Gerrit J. J. van den Burg   +1 more
openaire   +2 more sources

Change-point detection in a sequence of bags-of-data [PDF]

open access: yes2016 IEEE 32nd International Conference on Data Engineering (ICDE), 2015
In this paper, the limitation that is prominent in most existing works of change-point detection methods is addressed by proposing a nonparametric, computationally efficient method. The limitation is that most works assume that each data point observed at each time step is a single multi-dimensional vector. However, there are many situations where this
Kensuke Koshijima   +2 more
openaire   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

A backward procedure for change-point detection with applications to copy number variation detection

open access: yes, 2019
Change-point detection regains much attention recently for analyzing array or sequencing data for copy number variation (CNV) detection. In such applications, the true signals are typically very short and buried in the long data sequence, which makes it ...
Hao, Ning, Shin, Seung Jun, Wu, Yichao
core   +1 more source

Adversarially robust change point detection

open access: yes, 2021
Change point detection is becoming increasingly popular in many application areas. On one hand, most of the theoretically-justified methods are investigated in an ideal setting without model violations, or merely robust against identical heavy-tailed noise distribution across time and/or against isolate outliers; on the other hand, we are aware that ...
Mengchu Li, Yi Yu
openaire   +3 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Non-parametric change-point method for differential gene expression detection. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: We proposed a non-parametric method, named Non-Parametric Change Point Statistic (NPCPS for short), by using a single equation for detecting differential gene expression (DGE) in microarray data.
Yao Wang   +4 more
doaj   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy